濰柴動力(000338.SZ):自主研發的農業裝備CVT(無極變速)動力總成,填補國內技術空白,實現國產化替代
格隆匯2月21日丨濰柴動力(000338.SZ)於2023年2月17日15:00-17:30接受機構調研時表示,農業裝備行業前景較好,大馬力化和智能化是行業未來趨勢,隨着行業競爭格局向頭部集聚,濰柴雷沃作為龍頭企業有望顯著受益。同時,在高端大馬力化趨勢下,濰柴和雷沃的協同優勢將更加明顯,濰柴自主研發的農業裝備CVT(無極變速)動力總成,填補國內技術空白,實現國產化替代,目前已進入商業化應用階段,未來公司將積極把握政策及行業發展機遇,繼續推動相關產品的進一步快速上量。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.